Previous 10 | Next 10 |
2024-03-30 12:13:00 ET The Health Care Select Sector SPDR Fund ETF ( NYSEARCA: XLV ), tracking the healthcare companies under S&P 500, rose 8.32% in the first quarter of 2024, lagging slightly behind the broader S&P 500 index which rose 10.16%.... Read the full article...
2024-03-29 19:46:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...
2024-03-28 15:00:00 ET More on the markets Where This Market Is Going (Technical Analysis) SPY: 2 Opposing Forces Wall Street Lunch: Fed Not Spooked By Recent Inflation Overbought conditions flash across all market caps: Bespoke Investment Group Energ...
2024-03-27 10:24:23 ET More on Medtronic Medtronic: Buy This Dividend Aristocrat Diamond In The Rough Now Medtronic plc (MDT) Management presents at 2024 Barclays 26th Annual Healthcare Conference (Transcript) Medtronic: Undervalued Medical Devices Stock With Robust ...
Vancouver, British Columbia--(Newsfile Corp. - March 25, 2024) - East West Petroleum Corp. (TSXV: EW) ("East West" or the "Company") is pleased to provide this update in regard to the status of the sale of the New Zealand oil and gas properties. Pursuant to the terms of the purchase and sale a...
2024-03-20 07:44:44 ET More on the markets SPY: Assessing Economic Risks And Market Trends (Technical Analysis, Rating Downgrade) SPY Is Expensive, But There Are Hiding Places S&P 500: Time To Hedge, Here's How Bull vs. Bear: What’s next for the S&...
Edwards Lifesciences (NYSE: EW) announced today at Cardiovascular Research Technologies (CRT) 2024 the compelling results from two large, real-world studies based on TVT Registry data that demonstrated continued excellent outcomes for patients treated with the Edwards SAPIEN valve platform. A...
2024-03-07 14:12:00 ET More on Edwards Lifesciences Edwards Lifesciences: EVOQUE FDA Approval; Critical Care Spin-Off (Rating Maintained) Edwards Lifesciences Corporation (EW) Q4 2023 Earnings Call Transcript Edward Lifesciences: Still Not A Buy But Getting Closer ...
Edwards Lifesciences Corporation (NYSE: EW) today announced it will participate in the TD Cowen Healthcare Conference on Tuesday, March 5, 2024. Bernard Zovighian, chief executive officer, and Scott Ullem, chief financial officer, are scheduled to present at 10:30 a.m. ET. A live webcast of t...
Vancouver, British Columbia--(Newsfile Corp. - February 23, 2024) - East West Petroleum Corp. (TSXV: EW) ("East West" or the "Company") is pleased to comment on its financial results for the nine months ended December 31, 2023. During the nine months ended December 31, 2023, the Company genera...
News, Short Squeeze, Breakout and More Instantly...
Edwards Lifesciences Corporation Company Name:
EW Stock Symbol:
NYSE Market:
Edwards Lifesciences Corporation Website:
On CNBC's “Mad Money Lightning Round,” Jim Cramer said the new product line of Edwards Lifesciences Corporation (NYSE:EW) is ̶...
Edwards Lifesciences (NYSE:EW) has outperformed the market over the past 15 years by 8.25% on an annualized basis producing an average annual retur...
Repsol S.A ADR (REPYY) is expected to report $0.86 for Q1 2024 Chugai Pharmaceutical Co Ltd ADR (CHGCY) is expected to report for Q1 2024 CBIZ Inc. (CBZ) is expected to report $1.57 for Q1 2024 Financial Institutions Inc. (FISI) is expected to report $0.66 for Q1 2024 Caterpillar ...